Literature DB >> 23049808

LMNA knock-down affects differentiation and progression of human neuroblastoma cells.

Giovanna Maresca1, Manuela Natoli, Marta Nardella, Ivan Arisi, Daniela Trisciuoglio, Marianna Desideri, Rossella Brandi, Simona D'Aguanno, Maria Rita Nicotra, Mara D'Onofrio, Andrea Urbani, Pier Giorgio Natali, Donatella Del Bufalo, Armando Felsani, Igea D'Agnano.   

Abstract

BACKGROUND: Neuroblastoma (NB) is one of the most aggressive tumors that occur in childhood. Although genes, such as MYCN, have been shown to be involved in the aggressiveness of the disease, the identification of new biological markers is still desirable. The induction of differentiation is one of the strategies used in the treatment of neuroblastoma. A-type lamins are components of the nuclear lamina and are involved in differentiation. We studied the role of Lamin A/C in the differentiation and progression of neuroblastoma. METHODOLOGY/PRINCIPAL
FINDINGS: Knock-down of Lamin A/C (LMNA-KD) in neuroblastoma cells blocked retinoic acid-induced differentiation, preventing neurites outgrowth and the expression of neural markers. The genome-wide gene-expression profile and the proteomic analysis of LMNA-KD cells confirmed the inhibition of differentiation and demonstrated an increase of aggressiveness-related genes and molecules resulting in augmented migration/invasion, and increasing the drug resistance of the cells. The more aggressive phenotype acquired by LMNA-KD cells was also maintained in vivo after injection into nude mice. A preliminary immunohistochemistry analysis of Lamin A/C expression in nine primary stages human NB indicated that this protein is poorly expressed in most of these cases.
CONCLUSIONS/SIGNIFICANCE: We demonstrated for the first time in neuroblastoma cells that Lamin A/C plays a central role in the differentiation, and that the loss of this protein gave rise to a more aggressive tumor phenotype.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23049808      PMCID: PMC3458895          DOI: 10.1371/journal.pone.0045513

Source DB:  PubMed          Journal:  PLoS One        ISSN: 1932-6203            Impact factor:   3.240


  44 in total

1.  Altered expression of endoplasmic reticulum aminopeptidases ERAP1 and ERAP2 in transformed non-lymphoid human tissues.

Authors:  Doriana Fruci; Patrizio Giacomini; Maria R Nicotra; Matteo Forloni; Rocco Fraioli; Loredana Saveanu; Peter van Endert; Pier Giorgio Natali
Journal:  J Cell Physiol       Date:  2008-09       Impact factor: 6.384

Review 2.  The nuclear membrane and mechanotransduction: impaired nuclear mechanics and mechanotransduction in lamin A/C deficient cells.

Authors:  Jan Lammerding; Richard T Lee
Journal:  Novartis Found Symp       Date:  2005

3.  International neuroblastoma pathology classification for prognostic evaluation of patients with peripheral neuroblastic tumors: a report from the Children's Cancer Group.

Authors:  H Shimada; S Umehara; Y Monobe; Y Hachitanda; A Nakagawa; S Goto; R B Gerbing; D O Stram; J N Lukens; K K Matthay
Journal:  Cancer       Date:  2001-11-01       Impact factor: 6.860

Review 4.  Neuroblastoma as an experimental model for neuronal differentiation and hypoxia-induced tumor cell dedifferentiation.

Authors:  Anders Edsjö; Linda Holmquist; Sven Påhlman
Journal:  Semin Cancer Biol       Date:  2006-05-10       Impact factor: 15.707

5.  Bcl-2 overexpression in melanoma cells increases tumor progression-associated properties and in vivo tumor growth.

Authors:  Daniela Trisciuoglio; Marianna Desideri; Ludovica Ciuffreda; Marcella Mottolese; Domenico Ribatti; Angelo Vacca; Mario Del Rosso; Lucia Marcocci; Gabriella Zupi; Donatella Del Bufalo
Journal:  J Cell Physiol       Date:  2005-12       Impact factor: 6.384

6.  Strongylophorine-26, a Rho-dependent inhibitor of tumor cell invasion that reduces actin stress fibers and induces nonpolarized lamellipodial extensions.

Authors:  Lianne M McHardy; Kaoru Warabi; Raymond J Andersen; Calvin D Roskelley; Michel Roberge
Journal:  Mol Cancer Ther       Date:  2005-05       Impact factor: 6.261

7.  Nuclear lamin A/C deficiency induces defects in cell mechanics, polarization, and migration.

Authors:  Jerry S H Lee; Christopher M Hale; Porntula Panorchan; Shyam B Khatau; Jerry P George; Yiider Tseng; Colin L Stewart; Didier Hodzic; Denis Wirtz
Journal:  Biophys J       Date:  2007-07-13       Impact factor: 4.033

8.  Cell type-specific expression of nuclear lamina proteins during development of Xenopus laevis.

Authors:  R Benavente; G Krohne; W W Franke
Journal:  Cell       Date:  1985-05       Impact factor: 41.582

9.  Nuclear envelope structural defects cause chromosomal numerical instability and aneuploidy in ovarian cancer.

Authors:  Callinice D Capo-chichi; Kathy Q Cai; Fiona Simpkins; Parvin Ganjei-Azar; Andrew K Godwin; Xiang-Xi Xu
Journal:  BMC Med       Date:  2011-03-26       Impact factor: 8.775

Review 10.  Nuclear lamins: key regulators of nuclear structure and activities.

Authors:  Miron Prokocimer; Maya Davidovich; Malka Nissim-Rafinia; Naama Wiesel-Motiuk; Daniel Z Bar; Rachel Barkan; Eran Meshorer; Yosef Gruenbaum
Journal:  J Cell Mol Med       Date:  2009-02-04       Impact factor: 5.310

View more
  19 in total

1.  Regulatory mechanism of ZNF139 in multi-drug resistance of gastric cancer cells.

Authors:  Yong Li; Bi-bo Tan; Qun Zhao; Li-qiao Fan; Yü Liu; Dong Wang
Journal:  Mol Biol Rep       Date:  2014-02-11       Impact factor: 2.316

2.  Lamin A/C Is Required for ChAT-Dependent Neuroblastoma Differentiation.

Authors:  Loredana Guglielmi; Marta Nardella; Carla Musa; Ilaria Iannetti; Ivan Arisi; Mara D'Onofrio; Andrea Storti; Alessandra Valentini; Emanuele Cacci; Stefano Biagioni; Gabriella Augusti-Tocco; Igea D'Agnano; Armando Felsani
Journal:  Mol Neurobiol       Date:  2016-05-25       Impact factor: 5.590

3.  Lamin A/C deficiency is an independent risk factor for cervical cancer.

Authors:  Callinice D Capo-chichi; Blanche Aguida; Nicodème W Chabi; Qi K Cai; Georges Offrin; Vidéhouénou K Agossou; Ambaliou Sanni; Xiang-Xi Xu
Journal:  Cell Oncol (Dordr)       Date:  2015-11-04       Impact factor: 6.730

4.  Human placenta-derived neurospheres are susceptible to transformation after extensive in vitro expansion.

Authors:  Donatella Amendola; Marta Nardella; Loredana Guglielmi; Lidia Cerquetti; Elisabetta Carico; Viola Alesi; Manuela Porru; Carlo Leonetti; Claudia Bearzi; Roberto Rizzi; Igea D'Agnano; Antonio Stigliano; Giuseppe Novelli; Barbara Bucci
Journal:  Stem Cell Res Ther       Date:  2014-04-22       Impact factor: 6.832

5.  Down-regulation of the Lamin A/C in neuroblastoma triggers the expansion of tumor initiating cells.

Authors:  Marta Nardella; Loredana Guglielmi; Carla Musa; Ilaria Iannetti; Giovanna Maresca; Donatella Amendola; Manuela Porru; Elisabetta Carico; Giuseppe Sessa; Rosalba Camerlingo; Carlo Dominici; Francesca Megiorni; Marika Milan; Claudia Bearzi; Roberto Rizzi; Giuseppe Pirozzi; Carlo Leonetti; Barbara Bucci; Delio Mercanti; Armando Felsani; Igea D'Agnano
Journal:  Oncotarget       Date:  2015-10-20

Review 6.  A Novel Role of Lamins from Genetic Disease to Cancer Biomarkers.

Authors:  Kunnathur Murugesan Sakthivel; Poonam Sehgal
Journal:  Oncol Rev       Date:  2016-11-14

7.  The laminA/NF-Y protein complex reveals an unknown transcriptional mechanism on cell proliferation.

Authors:  Lucia Cicchillitti; Isabella Manni; Carmine Mancone; Giulia Regazzo; Manuela Spagnuolo; Tonino Alonzi; Fabrizio Carlomosti; Maria Lucia Dell'Anna; Giulia Dell'Omo; Mauro Picardo; Paolo Ciana; Maurizio C Capogrossi; Marco Tripodi; Alessandra Magenta; Maria Giulia Rizzo; Aymone Gurtner; Giulia Piaggio
Journal:  Oncotarget       Date:  2017-01-10

8.  MYCN gene expression is required for the onset of the differentiation programme in neuroblastoma cells.

Authors:  L Guglielmi; C Cinnella; M Nardella; G Maresca; A Valentini; D Mercanti; A Felsani; I D'Agnano
Journal:  Cell Death Dis       Date:  2014-02-20       Impact factor: 8.469

9.  Novel downstream molecular targets of SIRT1 in melanoma: a quantitative proteomics approach.

Authors:  Chandra K Singh; Jasmine George; Minakshi Nihal; Grzegorz Sabat; Raj Kumar; Nihal Ahmad
Journal:  Oncotarget       Date:  2014-04-15

10.  CDDO and ATRA Instigate Differentiation of IMR32 Human Neuroblastoma Cells.

Authors:  Namrata Chaudhari; Priti Talwar; Christian Lefebvre D'hellencourt; Palaniyandi Ravanan
Journal:  Front Mol Neurosci       Date:  2017-09-26       Impact factor: 5.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.